SIGN UP
LOG IN
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Benzinga·03/11/2025 13:14:54
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Keefe, Bruyette & Woods analyst Jade Rahmani downgraded the rating for Lennar Corporation (NYSE:LEN) from Outperform to Market Perform and lowered the price target from $152 to $141. Lennar shares closed at $125.22 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Mauricio Cepeda downgraded Afya Limited (NASDAQ:AFYA) from Equal-Weight to Underweight and cut the price target from $19 to $17. Afya shares closed at $16.97 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Joseph Pantginis downgraded the rating for Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) from Buy to Neutral and announced a $4.1 price target. Checkpoint Therapeutics shares closed at $3.98 on Monday. See how other analysts view this stock.
- Jefferies analyst Laurence Alexander downgraded the rating for Green Plains Inc. (NASDAQ:GPRE) from Buy to Hold and lowered the price target from $14 to $6. Green Plains shares closed at $5.48 on Monday. See how other analysts view this stock.
- Leerink Partners analyst Daina Graybosch downgraded 2seventy bio, Inc. (NASDAQ:TSVT) from Outperform to Market Perform and lowered the price target from $9 to $5. 2seventy bio shares closed at $2.80 on Monday. See how other analysts view this stock.
Considering buying LEN stock? Here’s what analysts think:
Read This Next:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.